shutterstock_255876943_drug discovery d3

ISNTD d3 2022
Drug discovery, development & diagnostics
for neglected tropical diseases

Online conference 

29-30th June 2022




ISNTD d³ 2022 addresses the current gaps and collaboration opportunities across tropical diseases and diseases of poverty to accelerate drug discovery & development, vaccine R&D and uptake, and diagnostics and surveillance opportunities. 

This year, against the backdrop of the recently launched WHO NTD Roadmap and the shock of the COVID19 pandemic, ISNTD d³ will focus on the shifts, gaps and future needs of drug discovery, treatments and diagnostics in context of global health as well as broader challenges.

Presentations & panel discussions will run on both days, and partnership meetings can be arranged throughout the day.

Please contact for further details including speaking & attending and to become a conference sponsor.


Register here 

Thanks for submitting! Your registration has been successful.


ISNTD d3 2022: DAY 1

29 JUNE 2022

Session 1

Pipeline updates

Session 2

The future of vaccines for NTDs, from manufacturing to access 

Session 3

Challenges in financing new development in NTDs

Béatrice Greco - Head of  R&D and Access strategy of the Merck Global Health Institute, Merck 

Isaac T. Chikwanha, Senior Director, Investment Strategy, Access & Delivery, GHIT - Global Health Innovative Technology Fund 

Kishor Wasan Adjunct Professor & Distinguished University Scholar
Co-Director & Co-Founder, Neglected Global Diseases Initiative-University of British Colombia 

Session 4

Disease focus: sleeping sickness, de-risking discovery through partnerships and driving sustainability through access   

Philippe Neau Head of Neglected Tropical Diseases Program at Global Health Sanofi

Florent Mbo  Access Leader and Regional HATplatform Coordinator

Drugs for Neglected Diseases initiative (DNDi), RDC 

François Bompart DNDi ,Access Committee Chair, DNDi


ISNTD d3 2022: DAY 2

30 JUNE 2022

Session 1

NTD diagnostics & the future of disease elimination

Dr. Sarah Nogaro FIND 

Session 2

Novel point-of-care diagnostics 

Digital optical diagnostics for schistosomiasis and the Schistoscope

Dr. Temitope Agbana (Post-Doc, Delft University of Technology TU Delft and INSPiRED project)

Cygnus smartphone multiplex microcapillary diagnostics for rapid serotype-specific NS1 detection of dengue

Dr Alexander Edwards (Reading School of Pharmacy, University of Reading UK)


A handheld quantitative G6PD diagnostic tool to improve point-of-care malaria diagnosis

Dr Benedikt Ley (Senior Research Fellow, Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Australia)

Session 3

Molecular-based diagnostics for NTDs

Multiplex real-time qPCR assay for leprosy diagnosis

Dr Alexandre Dias Tavares Costa (Instituto de Biologia Molecular do Paraná, FIOCRUZ, Curitiba, Brazil, Laboratório de Ciências e Tecnologias Aplicadas à Saúde (LaCTAS), Instituto Carlos Chagas, Fundação Oswaldo Cruz/FIOCRUZ)

“Mail order” RNA-sequencing of single tapeworm egg isolates from stool samples for the diagnosis of Taenia solium infections 

Henrik Sadlowski (Charité-Universitätsmedizin Berlin; NeuroCure (NCRC) 

Session 4

Novel protein candidates for NTD diagnostics 

Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers

Dr Javier Sotillo (Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Australia and Instituto de Salud Carlos III, Spain)